PharmaCielo Income Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	3.48	1.54	5.31	1.94	2.65
Revenue Growth (YoY)	125.70%	-70.96%	172.93%	-26.71%	237.26%
Cost of Revenue	2.75	2.91	4.63	6.09	8.59
Gross Profit	0.73	-1.37	0.68	-4.15	-5.93
Selling, General & Admin	5.42	8.31	11.66	19.15	32.6
Depreciation & Amortization Expenses	0.21	0.34	0.45	1.32	1.48
Other Operating Expenses	0.82	4.26	1.27	0.42	3.94
Total Operating Expenses	6.45	12.91	13.38	20.89	38.01
Operating Income	-5.72	-14.28	-12.7	-25.03	-43.94
Interest Income	0	0	0	0	0.07
Interest Expense	-3.44	-2.86	-1.59	-0.56	-0.27
Other Non-Operating Income (Expense)	-0.34	-0.12	-1.73	-0.07	-1.1
Total Non-Operating Income (Expense)	-3.79	-2.98	-3.32	-0.63	-1.31
Pretax Income	-9.51	-17.26	-16.03	-25.66	-45.25
Net Income	-9.51	-16.3	-14.52	-26.63	-43.76
Net Income to Common	-9.51	-16.3	-14.52	-26.63	-43.76
Shares Outstanding (Basic)	176	160	151	146	113
Shares Outstanding (Diluted)	176	160	151	146	113
Shares Change (YoY)	9.77%	6.03%	3.67%	29.41%	17.17%
EPS (Basic)	-0.05	-0.10	-0.10	-0.18	-0.39
EPS (Diluted)	-0.05	-0.10	-0.10	-0.18	-0.39
Free Cash Flow	-1.97	-5.17	-10.4	-21.21	-28
Free Cash Flow Per Share	-	-0.03	-0.07	-0.15	-0.25
Gross Margin	21.00%	-88.78%	12.83%	-213.23%	-223.51%
Operating Margin	-164.44%	-926.05%	-239.28%	-1287.03%	-1655.77%
Profit Margin	-273.26%	-1057.09%	-273.45%	-1369.14%	-1648.73%
FCF Margin	-56.59%	-335.01%	-195.86%	-1090.55%	-1054.97%
EBITDA	-4.46	-12.86	-11.12	-23.78	-42.38
EBITDA Margin	-128.09%	-834.31%	-209.53%	-1222.43%	-1596.75%
EBIT	-5.72	-14.28	-12.7	-25.03	-43.94
EBIT Margin	-164.44%	-926.05%	-239.28%	-1287.03%	-1655.77%

Updated Dec 31, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.